Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 24/6/2019
SIETES contiene 92761 citas

 
 
 1 a 20 de 98 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Healy D. EMA acknowledges persistent sexual dysfunction after SSRIs & SNRIs. Rxisk 20019:11 de junio. [Ref.ID 103130]
2. Cita con resumen
Mitchell CM, Reed SD, Diem S, Larson JC, Newton KM, Ensrud KE, LaCroix AZ, Caan B, Guthrie KA. Efficacy of vaginal estradiol or vaginal moisturizer vs placebo for treating postmenopausal vulvovaginal symptoms. A randomized clinical trial. JAMA Intern Med 2018;178:681-90. [Ref.ID 102472]
5. Cita con resumen
Cunningham GR, Stephens-Shields AJ, Rosen RC, Wang C, Bhasin S, Matsumoto AM, Parsons JK, Gill TM, Molitch ME, Farrar JT, Cella D, Barrett-Connor E, Cauley JA, Cifelli D, Crandall JP, Ensrud KE, Gallagher L, Zeldow B, Lewis CE, Pahor M, Swerdloff RS, Hou X, Anton S, Basaria S, Diem SJ, Tabatabaie V, Ellenberg SS, Snyder PJ. Testosterone treatment and sexual function in older men with low testosterone levels. J Clin Endocrinol Metab 2016;101:3096-104. [Ref.ID 100597]
6.Tiene citas relacionadas Cita con resumen
Jaspers L, Feys F, Bramer WM, Franco OH, Leusink P, Laan ETM. Efficacy and safety of flibanserin for the treatment of hypoactive sexual desire disorder in women: a systematic review and meta-analysis. JAMA Intern Med 2016;176:453-62. [Ref.ID 100198]
7.Tiene citas relacionadas Cita con resumen
Woloshin S, Schwartz LM. US Food and Drug Administration approval of flibanserin: even the score does not add up. JAMA Intern Med 2016;176:439-42. [Ref.ID 100197]
8. Cita con resumen
Joffe HV, Chang C, Sewell C, Easley O, Nguyen C, Dunn S, Lehrfeld K, Lee L, Kim MJ, Slagle AF, Beitz J. FDA approval of flibanserin — Treating hypoactive sexual desire disorder. N Engl J Med 2016;374:101-4. [Ref.ID 100089]
9.Tiene citas relacionadas Cita con resumen
Jaspers L, Feys F, Franco OH, Leusink P, Laan ETM. Efficacy and safety of flibanserin for the treatment of hypoactive sexual desire disorder in women. A systematic review and meta-analysis. JAMA Intern Med 2016;176:453-62. [Ref.ID 100072]
10.Tiene citas relacionadas Cita con resumen
Woloshin S, Schwartz LM. US Food and Drug Administration approval of flibanserin. Even the score does not add up . JAMA Intern Med 2016;176:439-42. [Ref.ID 100071]
11. Cita con resumen
Anónimo. Flibanserin (Addyi) for hypoactive sexual desire disorder. Med Lett Drugs Ther 2015;57:133-5. [Ref.ID 99654]
12. Cita con resumen
Gellad WF, Flynn KE, Alexander C. Evaluation of flibanserin: science and advocacy at the FDA. JAMA 2015;314:869-70. [Ref.ID 99515]
13.Tiene citas relacionadas Cita con resumen
Roehr B. FDA committee recommends approval for “female Viagra”. BMJ 2015;350:h3097. [Ref.ID 99189]
14. Cita con resumen
Trenque T, Maura C, Herlem E, Vallet C, Sole E, Auriche P, Drame M. Reports of sexual disorders related to serotonin reuptake inhibitors in the French Pharmacovigilance Database: an example of underreporting. Drug Saf 2013;36:515-9. [Ref.ID 95771]
15. Cita con resumen
Bianchi-Demicheli F, Sekoranja L, Pechère-Bertschi A. Sexualité, coeur et chocolat. Rev Med Suisse 2013;9:624. [Ref.ID 95185]
16. Cita con resumen
Montastruc J-L. Médicaments et drogues à l'origine de dysfonctions érectiles. Bulletin d'Informations de Pharmacologie 2013;20:2. [Ref.ID 95184]
17. Cita con resumen
Hutchinson K, Cruisckshank K, Wylie K. A benefit-risk assessment of dapoxetine in the treatment of premature ejaculation. Drug Saf 2012;35:359-72. [Ref.ID 92784]
18.Tiene citas relacionadas
Michael NL. Oral preexposure prophylaxis for HIV - another arrow in the quiver?. N Engl J Med 2010;363:2663-5. [Ref.ID 89887]
19.Tiene citas relacionadas
Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, Guanira-Carranza JV, Ramírez-Cardich ME, Montoya-Herrera O, Fernández T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker L-G, Mayer KH, Kallás EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Deffechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J, Rooney JF, Jaffe HS, Martinez AI, Burns DN, Glidden DV, for the iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010;363:2587-99. [Ref.ID 89885]
Seleccionar todas
 
 1 a 20 de 98 siguiente >>